96 related articles for article (PubMed ID: 11182149)
1. Adenovirus-mediated expression of interleukin-1 receptor antagonist in swine cells in vitro and in vivo.
Morrison DF; Murtaugh MP
Vet Immunol Immunopathol; 2001 Jan; 78(1):71-81. PubMed ID: 11182149
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia.
Morrison DF; Foss DL; Murtaugh MP
Infect Immun; 2000 Aug; 68(8):4752-8. PubMed ID: 10899882
[TBL] [Abstract][Full Text] [Related]
3. Expression of mRNA encoding interleukin (IL)-10, IL-12p35 and IL-12p40 in lungs from pigs experimentally infected with Actinobacillus pleuropneumoniae.
Cho WS; Jung K; Kim J; Ha Y; Chae C
Vet Res Commun; 2005 Feb; 29(2):111-22. PubMed ID: 15730135
[TBL] [Abstract][Full Text] [Related]
4. Activation of Porcine Alveolar Macrophages by Actinobacillus pleuropneumoniae Lipopolysaccharide via the Toll-Like Receptor 4/NF-κB-Mediated Pathway.
Li B; Fang J; Zuo Z; Yin S; He T; Yang M; Deng J; Shen L; Ma X; Yu S; Wang Y; Ren Z
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29229731
[No Abstract] [Full Text] [Related]
5. Pathogenesis of porcine Actinobacillus pleuropneumonia, part II: roles of proinflammatory cytokines.
Huang H; Potter AA; Campos M; Leighton FA; Willson PJ; Haines DM; Yates WD
Can J Vet Res; 1999 Jan; 63(1):69-78. PubMed ID: 9918337
[TBL] [Abstract][Full Text] [Related]
6. Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adenovirus: effects on vector-induced inflammation.
McCoy RD; Davidson BL; Roessler BJ; Huffnagle GB; Simon RH
Gene Ther; 1995 Sep; 2(7):437-42. PubMed ID: 7584121
[TBL] [Abstract][Full Text] [Related]
7. Effects of pentoxifylline on inflammatory cytokine expression and acute pleuropneumonia in swine.
Myers MJ; Baarsch MJ; Murtaugh MP
Immunobiology; 2002 Mar; 205(1):17-34. PubMed ID: 11999342
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiologic correlates of acute porcine pleuropneumonia.
Baarsch MJ; Foss DL; Murtaugh MP
Am J Vet Res; 2000 Jun; 61(6):684-90. PubMed ID: 10850846
[TBL] [Abstract][Full Text] [Related]
9. Infection dynamics and acute phase response of an Actinobacillus pleuropneumoniae field isolate of moderate virulence in pigs.
Gómez-Laguna J; Islas A; Muñoz D; Ruiz A; Villamil A; Carrasco L; Quezada M
Vet Microbiol; 2014 Oct; 173(3-4):332-9. PubMed ID: 25201629
[TBL] [Abstract][Full Text] [Related]
10. Frequency of Th17 cells correlates with the presence of lung lesions in pigs chronically infected with Actinobacillus pleuropneumoniae.
Sassu EL; Ladinig A; Talker SC; Stadler M; Knecht C; Stein H; Frömbling J; Richter B; Spergser J; Ehling-Schulz M; Graage R; Hennig-Pauka I; Gerner W
Vet Res; 2017 Feb; 48(1):4. PubMed ID: 28166835
[TBL] [Abstract][Full Text] [Related]
11. In-situ hybridization for the detection of inflammatory cytokines (IL-1, TNF-alpha and IL-6) in pigs naturally infected with Actinobacillus pleuropneumoniae.
Choi C; Kwon D; Min K; Chae C
J Comp Pathol; 1999 Nov; 121(4):349-56. PubMed ID: 10542124
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying Actinobacillus pleuropneumoniae exotoxin ApxI induced expression of IL-1β, IL-8 and TNF-α in porcine alveolar macrophages.
Chen ZW; Chien MS; Chang NY; Chen TH; Wu CM; Huang C; Lee WC; Hsuan SL
Vet Res; 2011 Feb; 42(1):25. PubMed ID: 21314908
[TBL] [Abstract][Full Text] [Related]
13. Mucosal and serum IgA antibodies in pigs following infection with Actinobacillus pleuropneumoniae.
Loftager MK; Eriksen L; Nielsen R
Adv Exp Med Biol; 1995; 371B():935-8. PubMed ID: 7502930
[No Abstract] [Full Text] [Related]
14. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
15. Host-pathogen interplay at primary infection sites in pigs challenged with Actinobacillus pleuropneumoniae.
Sassu EL; Frömbling J; Duvigneau JC; Miller I; Müllebner A; Gutiérrez AM; Grunert T; Patzl M; Saalmüller A; von Altrock A; Menzel A; Ganter M; Spergser J; Hewicker-Trautwein M; Verspohl J; Ehling-Schulz M; Hennig-Pauka I
BMC Vet Res; 2017 Feb; 13(1):64. PubMed ID: 28245826
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae.
Inzana TJ; Glindemann G; Fenwick B; Longstreth J; Ward D
Vet Microbiol; 2004 Nov; 104(1-2):63-71. PubMed ID: 15530740
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae.
Baarsch MJ; Scamurra RW; Burger K; Foss DL; Maheswaran SK; Murtaugh MP
Infect Immun; 1995 Sep; 63(9):3587-94. PubMed ID: 7642295
[TBL] [Abstract][Full Text] [Related]
18. Oral immunization with lung-pathogenic bacteria is protective against defined challenge in a pig aerosol infection model.
Hensel A; Delventhal S; Windt H; Stockhofe-Zurwieden N; Pabst R; Petzoldt K
Adv Exp Med Biol; 1995; 371B():803-6. PubMed ID: 7502901
[No Abstract] [Full Text] [Related]
19. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of a protective Actinobacillus pleuropneumoniae antigen during the course of infection.
Hennig I; Teutenberg-Riedel B; Gerlach GF
Microb Pathog; 1999 Feb; 26(2):53-63. PubMed ID: 10090852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
